Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients

Despite the extraordinary advances achieved to beat COVID-19 disease, many questions remain unsolved, including the mechanisms of action of SARS-CoV-2 and which factors determine why individuals respond so differently to the viral infection. Herein, we performed an in silico analysis to identify hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Calderon-Dominguez, Maria, Trejo-Gutierrez, Eva, González-Rovira, Almudena, Beltrán-Camacho, Lucía, Rojas-Torres, Marta, Eslava-Alcón, Sara, Sanchez-Morillo, Daniel, Calderon-Dominguez, Juan, Martinez-Nicolás, Mª Pilar, Gonzalez-Beitia, Estibaliz, Nieto-Martín, Mª Dolores, Trujillo-Soto, Teresa, Rodríguez-Iglesias, Manuel A., Moreno, Juan A., Moreno-Luna, Rafael, Durán-Ruiz, Mª Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188110/
https://www.ncbi.nlm.nih.gov/pubmed/35721225
http://dx.doi.org/10.1016/j.omtn.2022.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188110/
https://www.ncbi.nlm.nih.gov/pubmed/35721225
http://dx.doi.org/10.1016/j.omtn.2022.06.006

Ejemplares similares